Ignite Creation Date:
2025-12-25 @ 4:31 AM
Ignite Modification Date:
2025-12-26 @ 3:34 AM
Study NCT ID:
NCT03765918
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-20
First Post:
2018-11-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-17
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-09-10
Completion Date Type:
ESTIMATED
First Submit Date:
2018-11-06
First Submit QC Date:
None
Study First Post Date:
2018-12-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-14
Results First Submit QC Date:
None
Results First Post Date:
2025-08-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-18
Last Update Post Date:
2025-08-20
Last Update Post Date Type:
ACTUAL